Medicines Usage Review (MUR) Service


The service consists of accredited pharmacists undertaking structured adherence-centred reviews with patients on multiple medicines, particularly those receiving medicines for long term conditions. The MUR process attempts to establish a picture of the patient's use of their medicines - both prescribed and non-prescribed. The review will help patients understand their therapy and it will identify any problems they are experiencing along with possible solutions.

Who to Refer

Patients on multiple medicines where poor adherence/ compliance with medicines is suspected:

  • Those who do not order their repeat medicines regularly
  • Those who are over-ordering their medicines
  • Those patients whose blood results suggest they may not be taking their medicines.

From 1 October 2011 three national target groups were also introduced:

  • patients taking high risk medicines (NSAIDS, anticoagulants, antiplatelets, diuretics)
  • patients recently discharged from hospital who had changes made to their medicines while they were in hospital. (Ideally within four to eight weeks of discharge)
  • patients with respiratory disease.

MURs can also be carried out on patients who are not within the target groups. We expect that pharmacists will select patients who will benefit from the MUR service. All patients who receive an MUR should experience the same level of service regardless of their condition, i.e. MURs cover all the patient's medicines not just those that fall within a target group.

Please note: when seeking/receiving advice in regard to patient care and making referrals, NHS Connecting for Health Information Governance standards and policies must be adhered to.


Pharmaceutical Services negotiating Committee resources on MURs

BMA/PSNC GP guidance on achieving value for money from MURs

Last updated: 26/04/2012

Update due: 26/04/2013